People · Operator
Named in public records as an officer, director or promoter · active 2015–2026 · Other Technology, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Provivi, Inc. | — | Other Technology | Series C | $130.9M | $2.7B | 2015 |
| Foldax, Inc. | — | Other | Series A | $38.7M | $39.4M | 2017 |
| Linnaeus Therapeutics, Inc. | — | Biotechnology | Series A | $23.7M | $11.7M | 2026 |
| Compellon Inc | — | Other Technology | Series A | $10.1M | $9.7M | 2018 |
James Demetriades at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Demetriades on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kenneth Charhut | 2 | 4 |
| Brant Heise | 1 | 10 |
| George Wallace | 1 | 8 |
| Ganesh Kishore | 1 | 7 |
| Scott Huennekens | 1 | 7 |
| Morteza Gharib | 1 | 5 |
| Greg Casciaro | 1 | 4 |
| Michael Poisel | 1 | 4 |
| Todd Thomson | 1 | 4 |
| PATRICK MOONEY | 1 | 4 |
| Patrick T. Mooney | 1 | 3 |
| Renee Masi | 1 | 3 |
| Ken Charhut | 1 | 3 |
| Mory Gharib | 1 | 3 |
| PAUL KUC | 1 | 2 |
| Rick Farnell | 1 | 2 |
| Frances Arnold | 1 | 2 |
| James T. Demetriades | 1 | 2 |
| Frank Maguire | 1 | 1 |
| Jerry Pellizzon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.